John Kelly

Biography

John has successfully worked in medical device product commercialisation for more than 15 years, focusing on the delivery of solutions that improve usability and reliability. He led the New Product Implementation Group at ResMed, where he managed the design and commercialisation of the Mirage Swift mask. John was then Chief Operating Officer at ASX listed, now NASDAQ listed Unilife Corporation, where he led commercialisation of ‘Unifill’, the world’s first glass prefilled drug delivery device with integrated auto retract safety. This technology was licensed to Sanofi Aventis, securing US$47 million in licence and development fees. John set up Atomo Diagnostics in 2010 with the vision to develop & commercialise integrated diagnostics that are easy to use and highly accessible. In addition to his commercial experience, John has an Honours Degree in Mechanical Engineering from the University of Liverpool, a Master’s Degree in Systems Engineering from Queen’s University Belfast, as well as an Executive MBA from the University of Sydney where he was awarded the Business School’s inaugural ‘Excellence in Leadership’ scholarship.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management